A coroner has warned the Royal Pharmaceutical Society (RPS) that misinterpretation of 28-day-supply prescriptions can lead to patients developing “life-threatening” conditions.

The pharmacy regulator has “clear” government support to crack down on “rogue” weight loss jab providers, a health minister has warned.

Semaglutide and tirzepatide – also known as Wegovy and Mounjaro – have been featured in at least 63 “fatal” adverse reaction reports since they were licensed, C+D has learned.

“Flexible” weight loss jab service delivery models may see pharmacy at the front of rollout, the chief pharmaceutical officer (CPhO) for England has told C+D.

An NHSE official has said that while GPs will play a “very” central role in the 10-year health plan, the role of community pharmacy is “increasingly emerging” and needs to “grow”.

Revealing her spending review today (June 11), Chancellor Rachel Reeves set out a boost to NHS funding. The government will invest “an extra £29bn per year for the day-to-day running of our health ...

The medicines watchdog is conducting a safety review into the vaccine for chikungunya after serious adverse reactions including two deaths were reported globally, it has revealed.

An auction of an autobiography by the late Queen’s pharmacist has “raised £1,750 for…Rennie Grove Peace Hospice”, he today (June 9) told C+D. Uma Patel, who is also Avicenna’s former director, ...

New legislation is set to stop any new distance selling pharmacies (DSPs) from opening amid concerns that there are already “more than sufficient” numbers.

Some 96% of National Pharmacy Association (NPA) members have reported “challenges supplying” Creon that have led some cancer patients to ration the drug, the body has warned.

Over £100 million has been set aside to regenerate a “disused” Boots brownfield site into a housing development in a “stunning” location, a developer has revealed.

An intravenous (IV) iron supplier has agreed to pay the government millions after the competition authority found that its “potentially misleading” claims “could have had a financial impact on the NHS ...